Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

NRX Pharmaceuticals, Inc.

NASDAQ: NRXP · Life Sciences · 6 alerts · CIK 1719406

Share price
$2.15Close, Nov 16
Market cap
$93.1M
Shares outstanding
43.3MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All NRX Pharmaceuticals, Inc. filings on SEC EDGAR ↗

5:01 PM ET 8-K
Contract Win

NRX Pharmaceuticals Wins $11.2M Contract from Defense Advanced Research Projects Agency

NRx Defense Systems, a subsidiary of NRx Pharmaceuticals, was awarded an $11.2 million prime contract from DARPA to conduct the SPARC-TMS clinical trial. The trial evaluates a single-day treatment protocol combining robotic neuro-navigated transcranial magnetic stimulation with the company's investigational drug, NRX-101, for treatment-resistant depression. The contract includes an initial obligation of $6.7 million with additional funding subject to appropriations and performance milestones.

Value
$11.2M
Counterparty
Defense Advanced Research Projects Agency (DARPA)
Term
18 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.